Exact Sciences (EXAS) Cash & Current Investments (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Cash & Current Investments data on file, last reported at $964.7 million in Q4 2025.

• Cash & Current Investments for Q4 2025 came in at $964.7 million, down 7.06% year-over-year; the trailing twelve-month figure through Dec 2025 was $964.7 million (down 7.06% YoY), and the FY2025 annual result was $964.7 million, down 7.06% from the prior year.
• Cash & Current Investments eased to $964.7 million in Q4 2025 per EXAS's latest filing, from $1.0 billion in the prior quarter.
• Over five years, Cash & Current Investments peaked at $1.4 billion in Q1 2021 and troughed at $213.0 million in Q2 2025.
• A 5-year average of $869.6 million and a median of $801.6 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments surged 39.04% in 2024, then tumbled 77.5% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $1.0 billion in 2021, then tumbled by 38.66% to $632.1 million in 2022, then advanced by 23.03% to $777.6 million in 2023, then soared by 33.48% to $1.0 billion in 2024, then fell by 7.06% to $964.7 million in 2025.
• Business Quant data shows EXAS's Cash & Current Investments at $964.7 million in Q4 2025, $1.0 billion in Q3 2025, and $213.0 million in Q2 2025.